Skip to main content
Caplight Logo









VintaBio

VintaBio

Private
Philadelphia, PennsylvaniaHealthcare & Life Scienceshttps://vintabio.com/

Last Round

Early Funding

Apr 11, 2023

Total Funding Raised

$64M

Company Overview

VintaBio is a biotechnology company that provides contract development and manufacturing services for viral vectors used in cell and gene therapies.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Biotech Equipment, Pharma Supply Chain

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

CDMOviral vector manufacturingAAV perfusiongene therapy manufacturingcell and gene therapyCGTbiologics manufacturingprocess developmentcGMP manufacturingviral vector productionanalytical testingbiotech manufacturingbioprocessingfull capsid yieldcontract manufacturing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

VintaBio Comparables

Compare VintaBio with similar companies based on industry and business-model similarity.

VintaBio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Ascend
90%
Advanced Medicine Partners
89%
Vector BioMed, Inc.
89%

VintaBio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Early FundingApr 11, 2023

Key People

Founding team and executive leadership

David Radspinner

Chief Executive Officer

Executive Team

VintaBio Investors

Notable investors and investment history

VintaBio investors
InvestorRounds
GE UK GroupEarly Funding
Decheng CapitalEarly Funding

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 15, 2025

    Presented proprietary VintaProcess data at the ASGCT Annual Meeting.

  • Jan 1, 2025

    Announced VintaProcess™ for analytical and process optimization.

VintaBio Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

VintaBio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about VintaBio's valuation, stock price, and market status.

Firmographic Details

HeadquartersPhiladelphia, Pennsylvania
Employee Range31
Year Founded2020
Last FundingApr 11, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?